SK Biopharmaceuticals Co Ltd Sustainability Reports
The company engages in the research, development, and commercialization of innovative treatments for central nervous system disorders and oncology.
Sector: Manufacturing
Country: South Korea
Exchange: Korea Exchange (KOSPI)
LEI: 9845004573839986EA59
FIGI: BBG002Q871G2
12 reports from 2020 to 2026